Live feed
·
PRReleasevia Quantisnow
ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPA (ImmunoPrecise Antibodies Ltd.) and more on Quantisnow.